Cited by 96

The DOI matches its Crossref record.

Wnt/β-catenin signaling pathway may regulate the expression of angiogenic growth factors in hepatocellular carcinoma

QU, BO, LIU, BING-RONG, DU, YA-JU, CHEN, JING, CHENG, YAN-QIU, XU, WEI, WANG, XIN-HONG·2014·Oncology Letters

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3892/ol.2014.1828

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 34

  1. Tsao, 2012, SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma, Hepatology, 56, 2277, 10.1002/hep.25933 · DOI
  2. Jiang, 2009, Short hairpin RNA targeting beta-catenin suppresses cell proliferation and induces apoptosis in human gastric carcinoma cells, Scand J Gastroenterol, 44, 1452, 10.3109/00365520903342166 · DOI
  3. Yoo, 2009, Mutational analysis of WTX gene in Wnt/ beta-catenin pathway in gastric, colorectal, and hepatocellular carcinomas, Dig Dis Sci, 54, 1011, 10.1007/s10620-008-0458-9 · DOI
  4. Mukherjee, 2012, Subtype-specific alterations of the Wnt signaling pathway in breast cancer: clinical and prognostic significance, Cancer Sci, 103, 210, 10.1111/j.1349-7006.2011.02131.x · DOI
  5. Kang, 2012, Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells, Mol Pharmacol, 82, 168, 10.1124/mol.112.078535 · DOI
  6. Scholer-Dahirel, 2011, Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/beta-catenin signaling, Proc Natl Acad Sci USA, 108, 17135, 10.1073/pnas.1104182108 · DOI
  7. Bjorklund, 2011, Evidence of a role for activation of Wnt/beta-catenin signaling in the resistance of plasma cells to lenalidomide, J Biol Chem, 286, 11009, 10.1074/jbc.M110.180208 · DOI · Paper page
  8. Gehrke, 2009, Targeting the WNT/beta-catenin/TCF/LEF1 axis in solid and haematological cancers: Multiplicity of therapeutic options, Eur J Cancer, 45, 2759, 10.1016/j.ejca.2009.08.003 · DOI
  9. Wang, 2009, Wnt/β-catenin signaling pathway may regulate cell cycle and expression of cyclin A and cyclin E protein in hepatocellular carcinoma cells, Cell Cycle, 8, 1567, 10.4161/cc.8.10.8489 · DOI
  10. Tannock, 1968, The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour, Br J Cancer, 22, 258, 10.1038/bjc.1968.34 · DOI · Paper page
  11. Li, 2011, Knockdown of VEGF receptor-1 (VEGFR-1) impairs macrophage infiltration, angiogenesis and growth of clear cell renal cell carcinoma (CRCC), Cancer Biol Ther, 12, 872, 10.4161/cbt.12.10.17672 · DOI
  12. Man, 2010, Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling, Clin Cancer Res, 16, 967, 10.1158/1078-0432.CCR-09-1487 · DOI
  13. Hu, 2012, Vascular endothelial growth factor promotes the expression of cyclooxygenase 2 and matrix metalloproteinases in Lewis lung carcinoma cells, Exp Ther Med, 4, 1045, 10.3892/etm.2012.702 · DOI
  14. Cole, 2013, Tissue factor as a novel target for treatment of breast cancer, Oncologist, 18, 14, 10.1634/theoncologist.2012-0322 · DOI
  15. Hamed, 2012, Apoptosis, angiogenesis, inflammation, and oxidative stress: basic interactions in patients with early and metastatic breast cancer, J Cancer Res Clin Oncol, 138, 999, 10.1007/s00432-012-1176-4 · DOI
  16. Cattaruzza, 2013, Multivalent proteoglycan modulation of FGF mitogenic responses in perivascular cells, Angiogenesis, 16, 309, 10.1007/s10456-012-9316-7 · DOI
  17. Calviello, 2007, Docosahexaenoic acid induces proteasome- dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2, Carcinogenesis, 28, 1202, 10.1093/carcin/bgl254 · DOI
  18. Stockmann, 2010, Loss of myeloid cell-derived vascular endothelial growth factor accelerates fibrosis, Proc Natl Acad Sci USA, 107, 4329, 10.1073/pnas.0912766107 · DOI
  19. Blavier, 2010, Stromelysin-1 (MMP-3) is a target and a regulator of Wnt1-induced epithelial-mesenchymal transition (EMT), Cancer Biol Ther, 10, 198, 10.4161/cbt.10.2.12193 · DOI
  20. Wu, 2007, Wnt signaling induces MMP expression and regulates T cell transmigration, Immunity, 26, 227, 10.1016/j.immuni.2006.12.007 · DOI
  21. Fire, 1998, Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans, Nature, 391, 806, 10.1038/35888 · DOI · Paper page
  22. Hannon, 2002, RNA interference, Nature, 418, 244, 10.1038/418244a · DOI
  23. Guo, 2010, Vascular endothelial growth factor receptor-2 in breast cancer, Biochim Biophys Acta, 1806, 108
  24. Qiu, 2007, RNA interference-mediated signal transducers and activators of transcription 3 gene silencing inhibits invasion and metastasis of human pancreatic cancer cells, Cancer Sci, 98, 1099, 10.1111/j.1349-7006.2007.00485.x · DOI
  25. Tsareva, 2007, Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction, Neoplasia, 9, 279, 10.1593/neo.06820 · DOI
  26. Chen, 2012, Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer, Mol Cancer Ther, 11, 277, 10.1158/1535-7163.MCT-11-0648 · DOI
  27. Wang, 2011, Silencing STAT3 may inhibit cell growth through regulating signaling pathway, telomerase, cell cycle, apoptosis and angiogenesis in hepatocellular carcinoma: potential uses for gene therapy, Neoplasma, 58, 158, 10.4149/neo_2011_02_158 · DOI
  28. Ding, 2008, Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma, Mol Cancer Ther, 7, 648, 10.1158/1535-7163.MCT-07-2229 · DOI
  29. Zhang, 2007, Inducing effects of hepatocyte growth factor on the expression of vascular endothelial growth factor in human colorectal carcinoma cells through MEK and PI3K signaling pathways, Chin Med J (Engl), 120, 743, 10.1097/00029330-200705010-00002 · DOI
  30. Wang, 2007, STAT3 mediates bone marrow mesenchymal stem cell VEGF production, J Mol Cell Cardiol, 42, 1009, 10.1016/j.yjmcc.2007.04.010 · DOI
  31. Yu, 2008, Beta2-Glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain, J Thromb Haemost, 6, 1215, 10.1111/j.1538-7836.2008.03000.x · DOI
  32. Hara, 2008, Androgen receptor and invasion in prostate cancer, Cancer Res, 68, 1128, 10.1158/0008-5472.CAN-07-1929 · DOI
  33. Chen, 2013, Sonic hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase/AKT signaling-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer, Carcinogenesis, 34, 10, 10.1093/carcin/bgs274 · DOI
  34. Segarra, 2012, Semaphorin 6A regulates angiogenesis by modulating VEGF signaling, Blood, 120, 4104, 10.1182/blood-2012-02-410076 · DOI

Cited by

Sorted by citations

Metadata

Authors
QU, B., LIU, B.-R., DU, Y.-J., CHEN, J., CHENG, Y.-Q., XU, W., & WANG, X.-H.
Venue
Oncology Letters
Published
2014-01-27
Volume
7
Issue
4
Pages
1175-1178
ISSN
  • 1792-1074
  • 1792-1082
Cited by
96
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review